Banced Corp’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,109
Closed -$360K 96
2018
Q3
$360K Buy
3,109
+178
+6% +$20.1K 0.61% 72
2018
Q2
$370K Sell
2,931
-279
-9% -$34K 0.63% 67
2018
Q1
$347K Sell
3,210
-201
-6% -$22.2K 0.62% 75
2017
Q4
$374K Sell
3,411
-36
-1% -$3.59K 0.62% 73
2017
Q3
$340K Buy
3,447
+298
+9% +$28.9K 0.59% 82
2017
Q2
$319K Buy
3,149
+255
+9% +$27.5K 0.59% 83
2017
Q1
$334K Buy
2,894
+84
+3% +$9.76K 0.61% 81
2016
Q4
$337K Buy
2,810
+99
+4% +$11K 0.64% 82
2016
Q3
$305K Sell
2,711
-91
-3% -$10.5K 0.6% 81
2016
Q2
$280K Buy
2,802
+290
+12% +$35K 0.52% 87
2016
Q1
$282K Sell
2,512
-87
-3% -$9.04K 0.49% 85
2015
Q4
$283K Sell
2,599
-203
-7% -$23.2K 0.51% 85
2015
Q3
$280K Sell
2,802
-110
-4% -$12K 0.52% 90
2015
Q2
$332K Sell
2,912
-89
-3% -$10.8K 0.45% 92
2015
Q1
$314K Buy
+3,001
New +$320K 0.44% 95

Other funds holding CLB

Banced Corp's CLB Position: Q4 2018 in Review

Banced Corp sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 3,109 shares — an estimated $360K sold.

Banced Corp first reported a position in CLB in Q1 2015 and held it in 15 quarters. The position peaked at $374K in Q4 2017. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Banced Corp reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Banced Corp sold 3,109 Core Laboratories shares in Q4 2018, an estimated $360K.
  • Banced Corp first reported a position in Core Laboratories in Q1 2015 and held it in 15 quarters.
  • Banced Corp's Core Laboratories position peaked at $374K in Q4 2017.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Banced Corp's 13F filing for Q4 2018, filed 14 Jan 2019.